Coralie Maizeray

AAV gene therapy / rare and ultra rare disease field Management of GLP biodistribution and toxicity studies: CROs management, presentation of results, scientific meeting, review of study document (study plan to report), coordination of experts, internal coordination Management of the non clinical part: Forecast budget, planning, coordination, meeting organization, reporting, timelines Strategy and operational plan for preclinical development creation of a database on specific regulatory GLP preclinical studies of ATMPs, particularly AAVs: meeting coordination, regulatory (FDA, EMA, ICH guidelines) monitoring for AAV treatment, decisional-making chart

AAV gene therapy / late clinical phase / rare and ultra rare disease / Pharmaceutical field

Management global: meeting organization, budget, planning, meeting report

Creation of risk analysis document: excel file, identification of relevant criteria, procedure creation

Creation of competitive intelligence document: excel file, coordination with BD, HAS preparation

Project management training: planning via Office Timeline, management and updating of budgets

with a project management tool (Planview).

Supervision of a young disabled person: CV, interview preparation, specialized company

Respiratory allergies / GLP / Pharmaceutical field Project comanagement: protocols, data analysis, reports, results presentation, plannification, GLP Sandwish ELISA assay optimization: saturation, buffer, kit comparison for for Alternaria alternata mould Protein structure analysis: western blot